Design: Advanced-stage nonsmall cell lung cancer patients who died from cancer at age ⩾65.5 years in 2001–2005 were selected from the
US Surveillance, Epidemiology, and End Results–Medicare database (N = 16,858) and the Ontario Cancer Registry (N = 8643). We estimated
total and service-specific costs (2009 US dollars) in each of the last 6 months of life from the public payer perspectives for short-term and
long-term survivors (lived